Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Orthocell Ltd ( (AU:OCC) ) has provided an update.
Orthocell Limited announced the issue of 3,000,000 unquoted options set to expire on October 31, 2027, with an exercise price of $0.67. This issuance is part of a previously announced transaction, which may impact the company’s financial strategy and offer stakeholders insights into its capital management plans.
More about Orthocell Ltd
Orthocell Limited is a company operating in the biotechnology sector, primarily focused on developing and commercializing regenerative medicine products to improve tissue repair and regeneration.
YTD Price Performance: 4.80%
Average Trading Volume: 1,527,492
Technical Sentiment Consensus Rating: Sell
Current Market Cap: A$340.4M
For a thorough assessment of OCC stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
- “You Want to Believe That You’re Not a Fool”: Tesla Stock (NASDAQ:TSLA) Slides as Customers Fight Back Against Self-Driving Promises
- AMD or Intel: Stifel Chooses the Better AI Chip Stock to Buy Ahead of Earnings
- “Move at a Glacial Pace”: Starbucks Stock (NASDAQ:SBUX) Slips With New Cross-Promotion Plan for The Devil Wears Prada 2

